Transient decrease in interleukin-7 availability arrests B lymphopoiesis during pregnancy

European Journal of Immunology

Volumn 38, Issue 2, 2008, Pages 381-390

  Bosco, Nabil ^a   Ceredig, Rhodri ^a,b   Rolink, Antonius ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

B cell development; Interleukin 7; Lymphopoiesis; Pregnancy

Indexed keywords

INTERLEUKIN 7; RECOMBINANT INTERLEUKIN 7; GROWTH INHIBITOR; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BIOAVAILABILITY; CELL CYCLE ARREST; CELL CYCLE PHASE; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; EARLY PROGENITOR WITH LYMPHOID AND MYELOID POTENTIAL; FEMALE; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOPOIESIS; MALE; MOUSE; NONHUMAN; PHASE TRANSITION; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; STEM CELL; ANIMAL; C57BL MOUSE; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PRE B LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; CELL LINE; DOWN-REGULATION; FEMALE; GROWTH INHIBITORS; IMMUNOPHENOTYPING; INTERLEUKIN-7; LYMPHOPOIESIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PRECURSOR CELLS, B-LYMPHOID; PREGNANCY; RECOMBINANT PROTEINS;

EID: 42249096486     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737665     Document Type: Article

References (52)

1. Matthias, P. and Rolink, A. G., Transcriptional networks in developing and mature B cells. Nat. Rev. Immunol. 2005. 5: 497-508.
2. Rolink, A. G., Andersson, J. and Melchers, F., Molecular mechanisms guiding late stages of B-cell development. Immunol. Rev. 2004. 197: 41-50.
3. Hardy, R. R., Kincade, P.W. and Dorshkind, K., The protean nature of cells in the B lymphocyte lineage. Immunity 2007. 26: 703-714.
4. + CD19 hematopoietic progenitor with potent lymphoid and myeloid developmental potential. Eur. J. Immunol. 2005. 35: 2019-2030.
5. Erlandsson, L., Licence, S., Gaspal, F., Bell, S., Lane, P., Corcoran, A. E. and Martensson, I. L., Impaired B-1 and B-2 B cell development and atypical splenic B cell structures in IL-7 receptor-deficient mice. Eur. J. Immunol. 2004. 34: 3595-3603.
6. Erlandsson, L., Licence, S., Gaspal, F., Lane, P., Corcoran, A. E. and Martensson, I. L., Both the pre-BCR and the IL-7Ralpha are essential for expansion at the pre-BII cell stage in vivo. Eur. J. Immunol. 2005. 35: 1969-1976.
7. Ceredig, R., Rolink, A. G., Melchers, F. and Andersson, J., The B cell receptor, but not the pre-B cell receptor, mediates arrest of B cell differentiation. Eur. J. Immunol. 2000. 30: 759-767.
8. Ceredig, R., Andersson, J., Melchers, F. and Rolink, A., Effect of deregulated IL-7 transgene expression on B lymphocyte development in mice expressing mutated pre-B cell receptors. Eur. J. Immunol. 1999. 29: 2797-2807.
9. Fry, T. J. and Mackall, C. L., Interleukin-7: From bench to clinic. Blood 2002. 99: 3892-3904.
10. Grabstein, K. H., Waldschmidt, T. J., Finkelman, F. D., Hess, B. W., Alpert, A. R., Boiani, N. E., Namen, A. E. and Morrissey, P. J., Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J. Exp. Med. 1993. 178: 257-264.
11. Morrissey, P. J., Conlon, P., Charrier, K., Braddy, S., Alpert, A., Williams, D., Namen, A. E. and Mochizuki, D., Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral lymphadenopathy. J. Immunol. 1991. 147: 561-568.
12. Sudo, T., Nishikawa, S., Ohno, N., Akiyama, N., Tamakoshi, M., Yoshida, H. and Nishikawa, S., Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc. Natl. Acad. Sci. USA 1993. 90: 9125-9129.
13. von Freeden-Jeffry, U., Vieira, P., Lucian, L. A., McNeil, T., Burdach, S. E. and Murray, R., Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 1995. 181: 1519-1526.
14. Peschon, J. J., Morrissey, P. J., Grabstein, K. H., Ramsdell, F. J., Maraskovsky, E., Gliniak, B. C., Park, L. S. et al., Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 1994. 180: 1955-1960.
15. Mertsching, E., Grawunder, U., Meyer, V., Rolink, T. and Ceredig, R., Phenotypic and functional analysis of B lymphopoiesis in interleukin-7- transgenic mice: Expansion of pro/pre-B cell number and persistence of B lymphocyte development in lymph nodes and spleen. Eur. J. Immunol. 1996. 26: 28-33.
16. Namen, A. E., Lupton, S., Hjerrild, K., Wignall, J., Mochizuki, D. Y., Schmierer, A., Mosley, B. et al., Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988. 333: 571-573.
17. Namen, A. E., Schmierer, A. E., March, C. J., Overell, R. W., Park, L. S., Urdal, D. L. and Mochizuki, D. Y., B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J. Exp. Med. 1988. 167: 988-1002.
18. Rolink, A. G., Winkler, T., Melchers, F. and Andersson, J., Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. J. Exp. Med. 2000. 191: 23-32.
19. Kincade, P. W., Medina, K. L., Payne, K. J., Rossi, M. I., Tudor, K. S., Yamashita, Y. and Kouro, T., Early B-lymphocyte precursors and their regulation by sex steroids. Immunol. Rev. 2000. 175: 128-137.
20. Erlandsson, M. C., Ohlsson, C., Gustafsson, J. A. and Carlsten, H., Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus. Immunology 2001. 103: 17-25.
21. Carlsten, H., Immune responses and bone loss: The estrogen connection. Immunol. Rev. 2005. 208: 194-206.
22. Medina, K. L. and Kincade, P. W., Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc. Natl. Acad. Sci. USA 1994. 91: 5382-5386.
23. Medina, K. L., Smithson, G. and Kincade, P. W., Suppression of B lymphopoiesis during normal pregnancy. J. Exp. Med. 1993. 178: 1507-1515.
24. Smithson, G., Medina, K., Ponting, I. and Kincade, P. W., Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J. Immunol. 1995. 155: 3409-3417.
25. Igarashi, H., Kouro, T., Yokota, T., Comp, P. C. and Kincade, P. W., Age and stage dependency of estrogen receptor expression by lymphocyte precursors. Proc. Natl. Acad. Sci. USA 2001. 98: 15131-15136.
26. Thurmond, T. S., Murante, F. G., Staples, J. E., Silverstone, A. E., Korach, K. S. and Gasiewicz, T. A., Role of estrogen receptor alpha in hematopoietic stem cell development and B lymphocyte maturation in the male mouse. Endocrinology 2000. 141: 2309-2318.
27. Couse, J. F., Lindzey, J., Grandien, K., Gustafsson, J. A. and Korach, K. S., Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 1997. 138: 4613-4621.
28. Ceredig, R., Rauch, M., Balciunaite, G. and Rolink, A. G., Increasing Flt3L availability alters composition of a novel bone marrow lymphoid progenitor compartment. Blood 2006. 108: 1216-1222.
29. Srivastava, S., Weitzmann, M. N., Kimble, R. B., Rizzo, M., Zahner, M., Milbrandt, J., Ross, F. P. and Pacifici, R., Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. J. Clin. Invest. 1998. 102: 1850-1859.
30. Srivastava, S., Weitzmann, M. N., Cenci, S., Ross, F. P., Adler, S. and Pacifici, R., Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J. Clin. Invest. 1999. 104: 503-513.
31. Roggia, C., Gao, Y., Cenci, S., Weitzmann, M. N., Toraldo, G., Isaia, G. and Pacifici, R., Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo. Proc. Natl. Acad. Sci. USA 2001. 98: 13960-13965.
32. Itoh, Y., Hayashi, H., Miyazawa, K., Kojima, S., Akahoshi, T. and Onozaki, K., 17beta-estradiol induces IL-1alpha gene expression in rheumatoid fibroblast-like synovial cells through estrogen receptor alpha (ERalpha) and augmentation of transcriptional activity of Sp1 by dissociating histone deacetylase 2 from ERalpha. J. Immunol. 2007. 178: 3059-3066.
33. Girasole, G., Jilka, R. L., Passeri, G., Boswell, S., Boder, G., Williams, D. C. and Manolagas, S. C., 17 Beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest. 1992. 89: 883-891.
34. Gao, Y., Qian, W. P., Dark, K., Toraldo, G., Lin, A. S., Guldberg, R. E., Flavell, R. A. et al., Estrogen prevents bone loss through transforming growth factor beta signaling in T cells. Proc. Natl. Acad. Sci. USA 2004. 101: 16618-16623.
35. Evans, M. J., Lai, K., Shaw, L. J., Harnish, D. C. and Chadwick, C. C., Estrogen receptor alpha inhibits IL-1beta induction of gene expression in the mouse liver. Endocrinology 2002. 143: 2559-2570.
36. Rolink, A., Kudo, A., Karasuyama, H., Kikuchi, Y. and Melchers, F., Longterm proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo. EMBO J. 1991. 10: 327-336.
37. Suda, T., Okada, S., Suda, J., Miura, Y., Ito, M., Sudo, T., Hayashi, S. et al., A stimulatory effect of recombinant murine interleukin-7 (IL-7) on B-cell colony formation and an inhibitory effect of IL-1 alpha. Blood 1989. 74: 1936-1941.
38. + B precursor cells by two distinct signals derived from IL-7 receptor and c-kit in a fully defined medium. J. Exp. Med. 1995. 182: 315-323.
39. Medina, K. L., Garrett, K. P., Thompson, L. F., Rossi, M. I., Payne, K. J. and Kincade, P. W., Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat. Immunol. 2001. 2: 718-724.
40. Igarashi, H., Gregory, S. C., Yokota, T., Sakaguchi, N. and Kincade, P. W., Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 2002. 17: 117-130.
41. Klinge, C. M., Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 2001. 29: 2905-2919.
42. Ambrosino, C., Cicatiello, L., Cobellis, G., Addeo, R., Sica, V., Bresciani, F. and Weisz, A., Functional antagonism between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription. Mol. Endocrinol. 1993. 7: 1472-1483.
43. Malayer, J. R., Cheng, J. and Woods, V. M., Estrogen responses in bovine fetal uterine cells involve pathways directed by both estrogen response element and activator protein-1. Biol. Reprod. 1999. 60: 1204-1210.
44. Jakacka, M., Ito, M., Weiss, J., Chien, P. Y., Gehm, B. D. and Jameson, J. L., Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J. Biol. Chem. 2001. 276: 13615-13621.
45. Cheng, A. S., Jin, V. X., Fan, M., Smith, L. T., Liyanarachchi, S., Yan, P. S., Leu, Y. W. et al., Combinatorial analysis of transcription factor partners reveals recruitment of c-Myc to estrogen receptor-alpha responsive promoters. Mol. Cell 2006. 21: 393-404.
46. Jin, V. X., Sun, H., Pohar, T. T., Liyanarachchi, S., Palaniswamy, S. K., Huang, T. H. and Davuluri, R. V., ERTargetDB: An integral information resource of transcription regulation of estrogen receptor target genes. J. Mol. Endocrinol. 2005. 35: 225-230.
47. Jin, V. X., Leu, Y. W., Liyanarachchi, S., Sun, H., Fan, M., Nephew, K. P., Huang, T. H. and Davuluri, R. V., Identifying estrogen receptor alpha target genes using integrated computational genomics and chromatin immunoprecipitation microarray. Nucleic Acids Res. 2004. 32: 6627-6635.
48. Weitzmann, M. N. and Pacifici, R., Estrogen deficiency and bone loss: An inflammatory tale. J. Clin. Invest. 2006. 116: 1186-1194.
49. Ryan, M. R., Shepherd, R., Leavey, J. K., Gao, Y., Grassi, F., Schnell, F. J., Qian, W. P. et. al., An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency. Proc. Natl. Acad. Sci. USA 2005. 102: 16735-16740.
50. Fisher, A. G., Burdet, C., LeMeur, M., Haasner, D., Gerber, P. and Ceredig, R., Lymphoproliferative disorders in all IL-7 transgenic mouse line. Leukemia 1993. 7 Suppl 2: S66-S68.
51. Guleria, I. and Sayegh, M. H., Maternal acceptance of the fetus: True human tolerance. J. Immunol. 2007. 178: 3345-3351.
52. Rolink, A., Grawunder, U., Winkler, T. H., Karasuyama, H. and Melchers, F., IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int. Immunol. 1994. 6: 1257-1264.